These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 27746352)

  • 21. When proteostasis goes bad: Protein aggregation in the cell.
    Radwan M; Wood RJ; Sui X; Hatters DM
    IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of molecular chaperones in neurodegenerative disorders.
    Meriin AB; Sherman MY
    Int J Hyperthermia; 2005 Aug; 21(5):403-19. PubMed ID: 16048838
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Folding superfunnel to describe cooperative folding of interacting proteins.
    Smeller L
    Proteins; 2016 Jul; 84(7):1009-16. PubMed ID: 27090200
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nanoparticle-induced folding and fibril formation of coiled-coil-based model peptides.
    Wagner SC; Roskamp M; Pallerla M; Araghi RR; Schlecht S; Koksch B
    Small; 2010 Jun; 6(12):1321-8. PubMed ID: 20517875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protein folding and diseases.
    Lee C; Yu MH
    J Biochem Mol Biol; 2005 May; 38(3):275-80. PubMed ID: 15943901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferences of Silica Nanoparticles in Green Fluorescent Protein Folding Processes.
    Klein G; Devineau S; Aude JC; Boulard Y; Pasquier H; Labarre J; Pin S; Renault JP
    Langmuir; 2016 Jan; 32(1):195-202. PubMed ID: 26649773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cellular strategies to cope with protein aggregation.
    Scior A; Juenemann K; Kirstein J
    Essays Biochem; 2016 Oct; 60(2):153-161. PubMed ID: 27744331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Contribution of glutamatergic signaling to nitrosative stress-induced protein misfolding in normal brain aging and neurodegenerative diseases.
    Nakamura T; Gu Z; Lipton SA
    Aging Cell; 2007 Jun; 6(3):351-9. PubMed ID: 17388798
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamic molecular exchange and conformational transitions of alpha-synuclein at the nano-bio interface.
    Tira R; De Cecco E; Rigamonti V; Santambrogio C; Barracchia CG; Munari F; Romeo A; Legname G; Prosperi D; Grandori R; Assfalg M
    Int J Biol Macromol; 2020 Jul; 154():206-216. PubMed ID: 32179119
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein misfolding and neurodegeneration.
    Soto C; Estrada LD
    Arch Neurol; 2008 Feb; 65(2):184-9. PubMed ID: 18268186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbon Nanoparticles Inhibit the Aggregation of Prion Protein as Revealed by Experiments and Atomistic Simulations.
    Zhou S; Zhu Y; Yao X; Liu H
    J Chem Inf Model; 2019 May; 59(5):1909-1918. PubMed ID: 30575391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular chaperone dysfunction in neurodegenerative diseases and effects of curcumin.
    Maiti P; Manna J; Veleri S; Frautschy S
    Biomed Res Int; 2014; 2014():495091. PubMed ID: 25386560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune Responses to Soluble Aggregates of Amyloidogenic Proteins Involved in Neurodegenerative Diseases: Overlapping Aggregation Prone and Autoimmunogenic regions.
    Kumar S; Thangakani AM; Nagarajan R; Singh SK; Velmurugan D; Gromiha MM
    Sci Rep; 2016 Feb; 6():22258. PubMed ID: 26924748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How a cell deals with abnormal proteins. Pathogenetic mechanisms in protein aggregation diseases.
    Aigelsreiter A; Janig E; Stumptner C; Fuchsbichler A; Zatloukal K; Denk H
    Pathobiology; 2007; 74(3):145-58. PubMed ID: 17643060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methodological approaches and insights on protein aggregation in biological systems.
    Bastos P; Trindade F; Leite-Moreira A; Falcão-Pires I; Ferreira R; Vitorino R
    Expert Rev Proteomics; 2017 Jan; 14(1):55-68. PubMed ID: 27892738
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Misfolded Protein Linked Strategies Toward Biomarker Development for Neurodegenerative Diseases.
    Kumar S; Karthikeyan N; Mishra S; Padmanabhan P; Radda G; Gulyás B
    Mol Neurobiol; 2019 Apr; 56(4):2559-2578. PubMed ID: 30043261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proteostasis impairment in protein-misfolding and -aggregation diseases.
    Hipp MS; Park SH; Hartl FU
    Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reversible versus irreversible binding of transferrin to polystyrene nanoparticles: soft and hard corona.
    Milani S; Bombelli FB; Pitek AS; Dawson KA; Rädler J
    ACS Nano; 2012 Mar; 6(3):2532-41. PubMed ID: 22356488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanotechnology as a therapeutic tool to combat microbial resistance.
    Pelgrift RY; Friedman AJ
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1803-15. PubMed ID: 23892192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiamyloidogenic Chemical/Biochemical-Based Designed Nanoparticle as Artificial Chaperone for Efficient Inhibition of Protein Aggregation.
    Pradhan N; Debnath K; Mandal S; Jana NR; Jana NR
    Biomacromolecules; 2018 Jun; 19(6):1721-1731. PubMed ID: 29742346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.